Rio de Janeiro – June 8, 2016. SOLACI-SBHCI 2016, the largest meeting on Interventional Cardiology in Latin America started with more than 1500 attendees. After the opening, by Congress President Marcelo Josén de Carvalho Cantarelli, we honored Dr. José Eduardo Sousa, the first to perform a coronary catheterization in Brazil, 50 years ago. After<a href="https://solaci.org/en/2016/06/15/june-8-2016/" title="Read more" >...</a>
Original Title: Stent Thrombosis with Drug Eluting Stents and Bioresorbable Scaffolds. Evidence from a Network Meta-Analysis of 147 trials. Reference: Kang S et al. J Am Coll Cardiol Intv 2016 doi 10.1016. Courtesy of Dr. Guillermo Migliaro. When treating heart disease, drug eluting stents (DES) have become essential for PCI. Its main advantage lies on<a href="https://solaci.org/en/2016/06/13/stent-thrombosis-comparative-analysis-between-bms-des-and-brs/" title="Read more" >...</a>
Original Title: Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes Reference: Shiv K. Agarwal et al. J Am Coll Cardiol Intv. 2016;9(10):1022-1031. Courtesy of Dr. Agustín Vecchia. At present, fractional flow reserve (FFR) has become the gold standard to define ischemia in intermediate lesions, and to<a href="https://solaci.org/en/2016/06/09/post-pci-ffr-outcome-and-prognosis-optimization/" title="Read more" >...</a>
Original Title: Aortic Regurgitation Following Transcatheter Aortic Valve Replacement: Impact of Preprocedural Left Ventricular Diastolic Filling Patterns on Late Clinical Outcomes. Reference: Amir Halkin, et al. Catheterization Cardiovascular Intervention 2016;87:1156-1163. Courtesy of Dr. Carlos Fava. Even though the mechanisms underlying post TAVI aortic regurgitation (ARpost) remain unclear, there is no question this complication is<a href="https://solaci.org/en/2016/06/01/bad-prognosis-in-patients-with-aortic-regurgitation-post-tavi/" title="Read more" >...</a>
Original Title: Impact of New-Onset Left Bundle Branch Block and Periprocedural Permanent Pacemaker Implantation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement. A Systematic Review and Meta-Analysis. Reference: Ander Regueiro et al. Circ Cardiovasc Interv. 2016 May;9(5). Available data on the clinical impact of the new-onset left bundle branch block (LBBB) and<a href="https://solaci.org/en/2016/05/30/post-tavi-pacemaker-implantation-does-not-increase-mortality/" title="Read more" >...</a>
Original Title: Transcatheter Aortic Valve Implantation for Paradoxical Low-Flow Low-Gradient Aortic Stenosis Patients. Reference: Nicolas Debry et al. Catheter Cardiovasc Interv. 2016 Mar;87(4):797-804. Courtesy of Dr. Carlos Fava. Approximately 10 to 13% of low-flow low-gradient severe aortic stenosis cases (LF-LG) have preserved left ventricular function. Its physiopathology remains unclear and it has been associated with a<a href="https://solaci.org/en/2016/04/14/tavi-in-low-flow-low-gradient/" title="Read more" >...</a>
The Internal Mammary Artery (IMA) is the preferred conduit for bypassing the left anterior descending artery (LAD) in patients undergoing coronary artery bypass grafting. There is no systematic evaluation of the frequency and predictors of IMA failure or long-term outcomes. The PREVENT IV included 1539 patients receiving IMA-LAD revascularization with 12 and 18 month<a href="https://solaci.org/en/2015/12/24/predictors-of-internal-mammary-artery-graft-failure/" title="Read more" >...</a>
Original Title: Hemodynamic. Functional and Clinical Responses to Pulmonary Artery Denervation with Pulmonary Artery Hypertension of Different Causes. Phase II Results from the Pulmonary Artery Denervation 1 study. Reference: Circ Cardiovasc Interv. 2015;8 Courtesy of Dr. Guillermo Migliaro. Hospital Alemán, Buenos Aires, Argentina. The mechanisms responsible for pulmonary artery hypertension (PAH) are multifactorial. PAH reduces<a href="https://solaci.org/en/2015/12/04/hemodynamic-functional-and-clinical-response-to-pulmonary-artery-denervation-in-patients-with-pulmonary-hypertension/" title="Read more" >...</a>
Original Title: Individualizing Treatment Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: An Analysis from the DAPT Study. Presenter: Yeh RW. Optimal dual antiplatelet therapy duration for patients receiving stents has started to become clearer, but a new scoring method (DAPT Score) may help single out patients who could either benefit or suffer from extended<a href="https://solaci.org/en/2015/11/20/dapt-substudy-score-to-personalize-optimal-dual-antiaggregation-therapy-duration/" title="Read more" >...</a>
XXVIII Jornadas SOLACI, 10° Región Centroamérica y el Caribe 12 y 13 de Noviembre de 2015 en San José de Costa Rica, Costa Rica